Literature DB >> 10224622

Personality and psychopathology in schizophrenia: the association between personality traits and symptoms.

P H Lysaker1, M D Bell, E Kaplan, T C Greig, G J Bryson.   

Abstract

Research has indicated that stable individual differences in personality exist among persons with schizophrenia, and that they likely predate the onset of illness. Little is known, however, about whether individual differences in personality are related to levels of psychopathology. This study tested the hypotheses that levels of Extroversion, Neuroticism, and Psychoticism are associated with symptomatology. Accordingly, measures of these dimensions of personality and of symptomatology were obtained simultaneously for 113 male subjects with schizophrenia or schizoaffective disorder. Next, subjects were characterized as having high or low levels on each personality dimension and their scores on the five components of the Positive Negative Syndrome Scale were compared using multivariate and univariate procedures. Results indicate that extroverted subjects had lower levels of Positive, Negative, and Emotional Discomfort symptoms, and higher levels of Excitement symptoms than introverted subjects. Subjects with higher levels of Neuroticism had higher levels of Positive and Emotional Discomfort symptoms than subjects with lower levels of Neuroticism. No differences in symptoms were found among subjects with higher versus lower levels of Psychoticism. Results suggest individual differences in personality are associated with psychopathology in schizophrenia and may help further explain the heterogeneity widely observed in this disorder.

Entities:  

Mesh:

Year:  1999        PMID: 10224622     DOI: 10.1080/00332747.1999.11024850

Source DB:  PubMed          Journal:  Psychiatry        ISSN: 0033-2747            Impact factor:   2.458


  8 in total

1.  Quality of life and temperament factors in schizophrenia: comparative study of patients, their siblings and controls.

Authors:  Rena Kurs; Herman Farkas; Michael Ritsner
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

2.  Cognitive task performance and symptoms contribute to personality abnormalities in first hospitalized schizophrenia.

Authors:  Ronald J Gurrera; Robert W McCarley; Dean Salisbury
Journal:  J Psychiatr Res       Date:  2014-04-12       Impact factor: 4.791

3.  Neural markers of emotional face perception across psychotic disorders and general population.

Authors:  Amri Sabharwal; Roman Kotov; Akos Szekely; Hoi-Chung Leung; Deanna M Barch; Aprajita Mohanty
Journal:  J Abnorm Psychol       Date:  2017-05-29

4.  Personality domains, duration of untreated psychosis, functioning, and symptom severity in first-episode psychosis.

Authors:  Michael T Compton; Roger Bakeman; Yazeed Alolayan; Pierfrancesco Maria Balducci; Francesco Bernardini; Beth Broussard; Anthony Crisafio; Sarah Cristofaro; Patrick Amar; Stephanie Johnson; Claire Ramsay Wan
Journal:  Schizophr Res       Date:  2015-07-22       Impact factor: 4.939

Review 5.  Affective traits in schizophrenia and schizotypy.

Authors:  William P Horan; Jack J Blanchard; Lee Anna Clark; Michael F Green
Journal:  Schizophr Bull       Date:  2008-07-29       Impact factor: 9.306

6.  Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia.

Authors:  Juan L Molina; María Calvó; Eduardo Padilla; Mara Balda; Gabriela González Alemán; Néstor V Florenzano; Gonzalo Guerrero; Danielle Kamis; Beatriz Molina Rangeon; Mercedes Bourdieu; Sergio A Strejilevich; Horacio A Conesa; Javier I Escobar; Igor Zwir; C Robert Cloninger; Gabriel A de Erausquin
Journal:  NPJ Schizophr       Date:  2017-01-11

7.  Aberrant Tendency of Noncurrent Emotional Experiences in Individuals at Ultra-High Risk for Psychosis.

Authors:  Eunchong Seo; Minji Bang; Eun Lee; Suk Kyoon An
Journal:  Psychiatry Investig       Date:  2018-09-05       Impact factor: 2.505

8.  Social function in schizophrenia and schizoaffective disorder: associations with personality, symptoms and neurocognition.

Authors:  Paul H Lysaker; Louanne W Davis
Journal:  Health Qual Life Outcomes       Date:  2004-03-16       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.